CT-901

N/A

Report date: 2026/04/02 13:24:26
NME

Base Information

Drug NameCT-901
Drug Alias NameCT-901CT901
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, HepatocellularOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAlpha Biopharma (Jiangsu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlpha Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, HepatocellularOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A